Gilead
Gilead committed to having clinical data ready for a low-dose TAF based regimen for children 2-12 years by late 2018/early 2019.
Committed by:
Gilead
Sub-Actions & Milestones
Sub-action Gilead.1

Having clinical data ready for a low-dose TAF based regimen for children 2-12 years by late 2018/early 2019.

-

-

-

Milestone Gilead.1.1

-

-

-

-

Document (s)

-

-

-

-

Updates

-

Updates

Notes

Responsible